| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $23.2M | — | — |
| Cost of Revenue | $18.7M | — | — |
| Gross Profit | $4.5M | — | — |
| R&D Expense | $1.2M | — | — |
| SG&A Expense | $7.9M | — | — |
| Operating Income | -$4.7M | — | — |
| Interest Expense | $7.3M | — | — |
| Pre-tax Income | -$14.9M | — | — |
| Income Tax | $43K | — | — |
| Net Income | -$15.0M | — | — |
| EPS (Basic) | -$0.43 | — | — |
| EPS (Diluted) | -$0.43 | — | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $20.8M | +19.0% | — |
| Inventory | $28.2M | -3.2% | — |
| Current Assets | $77.6M | -5.7% | — |
| Total Assets | $225.5M | -2.9% | — |
| Current Liabilities | $20.5M | -13.0% | — |
| Long-term Debt | $148.7M | +4.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $4.7M | — | — |
| Capital Expenditures | $1.1M | — | — |
| Investing Cash Flow | -$1.1M | — | — |
| Financing Cash Flow | -$256K | — | — |
| Free Cash Flow | $3.6M | — | — |
| Total Liabilities | $204.7M | +3.3% | — |
| Stockholders' Equity | -$28.4M | -100.2% | — |